PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects …
Biotechnology
US, Cranbury [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about PMV Pharmaceuticals, Inc.'s gradings, price targets and earnings estimates. None
Reported
Past Estimate Consensus
Future Estimate Consensus
PMV Pharmaceuticals, Inc. can't present any analysts estimates at the moment detail analysis.